<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>同写意 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-09T16:31:45+08:00</updated>
  <subtitle>一个以新药创制为核心，汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路，写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”，讲求“实用、实在、时效”的原则</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>生物医药投资项目专利尽职调查，价值与要点</title>
    <updated>2021-01-09T15:07:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/kFN-dZGb_GQveogyaxpNtQ</id>
    <link href="https://mp.weixin.qq.com/s/kFN-dZGb_GQveogyaxpNtQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021摩根会议周期间 SAPA与BioNJ联合推出网络研讨会</title>
    <updated>2021-01-09T15:07:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/Nn7ToZtOwUG1fZfvPr980w</id>
    <link href="https://mp.weixin.qq.com/s/Nn7ToZtOwUG1fZfvPr980w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>如何打造中国版Moderna？窥探生命科学领域颠覆性创新顶级推手的商业路径</title>
    <updated>2021-01-09T15:07:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/yplGjT5UOB61RczU-wIr5A</id>
    <link href="https://mp.weixin.qq.com/s/yplGjT5UOB61RczU-wIr5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意人物｜王印祥：SHP2/KRAS的借船出海！</title>
    <updated>2021-01-08T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/UZ2-hYtXQMLARK_IvGO9oQ</id>
    <link href="https://mp.weixin.qq.com/s/UZ2-hYtXQMLARK_IvGO9oQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨凌科药业任命王雪郦博士为首席医学官</title>
    <updated>2021-01-08T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/q1EOergcxj6_ZRi9GT18pQ</id>
    <link href="https://mp.weixin.qq.com/s/q1EOergcxj6_ZRi9GT18pQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>溶瘤病毒研发药企亦诺微一年内3次获投，多管线平台蓄势共发</title>
    <updated>2021-01-08T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/zjKsBMiSZMJT_Rl1qXufIA</id>
    <link href="https://mp.weixin.qq.com/s/zjKsBMiSZMJT_Rl1qXufIA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨黑永疆博士出任誉衡生物首席执行官（CEO）</title>
    <updated>2021-01-07T18:19:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/jGcugRr8zOSETfbBWmXoVg</id>
    <link href="https://mp.weixin.qq.com/s/jGcugRr8zOSETfbBWmXoVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨开拓药业公布普克鲁胺治疗新冠男性受试者试验最终数据</title>
    <updated>2021-01-07T18:19:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/zFE6NMnkrVEU_4lydVlkuQ</id>
    <link href="https://mp.weixin.qq.com/s/zFE6NMnkrVEU_4lydVlkuQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意发布丨火石创造A轮融资近亿元，加快数据驱动产业发展</title>
    <updated>2021-01-07T18:19:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/7Y9k4zRgXnL-yrMN_todDw</id>
    <link href="https://mp.weixin.qq.com/s/7Y9k4zRgXnL-yrMN_todDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意讨论︱细胞与基因治疗，是否会遭遇PD-1一样的命运?</title>
    <updated>2021-01-06T17:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/EWfObfSccXGlmQ0dHoz1iw</id>
    <link href="https://mp.weixin.qq.com/s/EWfObfSccXGlmQ0dHoz1iw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>老板们的IPO信仰，正在被打破</title>
    <updated>2021-01-06T17:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/QMR1lvA3fOiJ3_s3XyaBtQ</id>
    <link href="https://mp.weixin.qq.com/s/QMR1lvA3fOiJ3_s3XyaBtQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年终总结: 基因治疗2020新进展</title>
    <updated>2021-01-06T17:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/fY4cCBiLyRBpUnJHg51jTA</id>
    <link href="https://mp.weixin.qq.com/s/fY4cCBiLyRBpUnJHg51jTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意报告︱李靖：未来十年如何面向国际，布局中国抗体药物研发</title>
    <updated>2021-01-05T19:16:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/bSCf0XIwrY0UtXhsyT-YdQ</id>
    <link href="https://mp.weixin.qq.com/s/bSCf0XIwrY0UtXhsyT-YdQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《新英格兰医学杂志》综述：新冠疫苗的安全性</title>
    <updated>2021-01-05T19:16:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/vAALuJzuiWBbDAztbdhYSA</id>
    <link href="https://mp.weixin.qq.com/s/vAALuJzuiWBbDAztbdhYSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>你了解FDA紧急使用授权吗？</title>
    <updated>2021-01-05T19:16:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/SBnfVTIPYDIMXKtSttul_Q</id>
    <link href="https://mp.weixin.qq.com/s/SBnfVTIPYDIMXKtSttul_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亚盛医药斩获第9项FDA孤儿药认证，创中国药企之最</title>
    <updated>2021-01-05T19:16:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/mqeGqnIdDWBQK438_MmDRA</id>
    <link href="https://mp.weixin.qq.com/s/mqeGqnIdDWBQK438_MmDRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>写意讨论丨资本市场如何看待License-in模式？</title>
    <updated>2021-01-04T19:13:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/XLxTwwpOT2Qwc4u3-TSqDQ</id>
    <link href="https://mp.weixin.qq.com/s/XLxTwwpOT2Qwc4u3-TSqDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>五个切面，回看2020年国内医药产业“大变局”</title>
    <updated>2021-01-04T19:13:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/CrE2l84cPAJsknbhajnHlA</id>
    <link href="https://mp.weixin.qq.com/s/CrE2l84cPAJsknbhajnHlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药笔记2020</title>
    <updated>2021-01-04T19:13:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/Q-0M9DXUiiuAxBkiPxa8nA</id>
    <link href="https://mp.weixin.qq.com/s/Q-0M9DXUiiuAxBkiPxa8nA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>加科思SHP2抑制剂与PD-(L)1联合用药临床试验在中美两国获批</title>
    <updated>2021-01-04T19:13:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/MoUKXHMBTDkdAVb8eCG6Wg</id>
    <link href="https://mp.weixin.qq.com/s/MoUKXHMBTDkdAVb8eCG6Wg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>